Trial intelligence / Profile preview

Adjunctive clobazam versus clonazepam for uncontrolled focal epilepsy

RBR-4frcs6Recruiting

Sponsor
Universidade Federal de Pernambuco
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of clobazam and clonazepam in Focal Onset Epilepsy (2 arms), sponsored by Universidade Federal de Pernambuco. Primary endpoint: Efficacy of adjunctive therapy. Started May 2019; status: recruiting.

02

Drugs

clobazamclonazepam
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on RBR-4frcs6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4frcs6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call